Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving.

Gren M, Shahim P, Lautner R, Wilson DH, Andreasson U, Norgren N, Blennow K, Zetterberg H.

Brain Inj. 2016 Jul 7:1-5. [Epub ahead of print]

PMID:
27389622
2.

Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].

Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H.

EBioMedicine. 2016 May;7:287-288. doi: 10.1016/j.ebiom.2016.04.021. Epub 2016 Apr 20. No abstract available.

3.

Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.

Stanne TM, Åberg ND, Nilsson S, Jood K, Blomstrand C, Andreasson U, Blennow K, Zetterberg H, Isgaard J, Svensson J, Jern C.

Stroke. 2016 Jul;47(7):1943-5. doi: 10.1161/STROKEAHA.115.012383. Epub 2016 Jun 14.

PMID:
27301948
4.

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.

Kuhlmann J, Andreasson U, Pannee J, Bjerke M, Portelius E, Leinenbach A, Bittner T, Korecka M, Jenkins RG, Vanderstichele H, Stoops E, Lewczuk P, Shaw LM, Zegers I, Schimmel H, Zetterberg H, Blennow K; IFCC Working Group on Standardization of CSF proteins (WG-CSF).

Clin Chim Acta. 2016 May 20. pii: S0009-8981(16)30218-2. doi: 10.1016/j.cca.2016.05.014. [Epub ahead of print]

PMID:
27216941
5.

Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women.

Gustavsson C, Andersson Hall U, Pelanis A, Karlsson OI, Andersson L, Svedin P, Mallard C, Myntti A, Andreasson U, Zetterberg H, Blennow K, Holmäng A.

Obesity (Silver Spring). 2016 Jun;24(6):1299-304. doi: 10.1002/oby.21502. Epub 2016 Apr 30.

PMID:
27130070
6.

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.

Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius Å, Liman V, Norgren N, Blennow K, Zetterberg H.

Clin Chem Lab Med. 2016 Apr 12. pii: /j/cclm.ahead-of-print/cclm-2015-1195/cclm-2015-1195.xml. doi: 10.1515/cclm-2015-1195. [Epub ahead of print]

PMID:
27071153
7.

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, Hölttä M, Rosén C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H.

Lancet Neurol. 2016 Jun;15(7):673-84. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.

PMID:
27068280
8.

C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning.

Kalm M, Andreasson U, Björk-Eriksson T, Zetterberg H, Pekny M, Blennow K, Pekna M, Blomgren K.

Oncotarget. 2016 Apr 12;7(15):19382-94. doi: 10.18632/oncotarget.8400.

9.

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.

Lelental N, Brandner S, Kofanova O, Blennow K, Zetterberg H, Andreasson U, Engelborghs S, Mroczko B, Gabryelewicz T, Teunissen C, Mollenhauer B, Parnetti L, Chiasserini D, Molinuevo JL, Perret-Liaudet A, Verbeek MM, Andreasen N, Brosseron F, Bahl JM, Herukka SK, Hausner L, Frölich L, Labonte A, Poirier J, Miller AM, Zilka N, Kovacech B, Urbani A, Suardi S, Oliveira C, Baldeiras I, Dubois B, Rot U, Lehmann S, Skinningsrud A, Betsou F, Wiltfang J, Gkatzima O, Winblad B, Buchfelder M, Kornhuber J, Lewczuk P.

J Alzheimers Dis. 2016 Mar 1;52(1):51-64. doi: 10.3233/JAD-150883.

PMID:
26967210
10.

Serum erythropoietin and outcome after ischaemic stroke: a prospective study.

Åberg ND, Stanne TM, Jood K, Schiöler L, Blomstrand C, Andreasson U, Blennow K, Zetterberg H, Isgaard J, Jern C, Svensson J.

BMJ Open. 2016 Feb 25;6(2):e009827. doi: 10.1136/bmjopen-2015-009827.

11.

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.

Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H.

EBioMedicine. 2015 Nov 22;3:135-40. doi: 10.1016/j.ebiom.2015.11.036. eCollection 2016 Jan.

12.

Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football.

Oliver JM, Jones MT, Kirk KM, Gable DA, Repshas JT, Johnson TA, Andréasson U, Norgren N, Blennow K, Zetterberg H.

Med Sci Sports Exerc. 2016 Jun;48(6):974-82. doi: 10.1249/MSS.0000000000000875.

PMID:
26765633
13.

Serum Neurofilament Light in American Football Athletes over the Course of a Season.

Oliver JM, Jones MT, Kirk KM, Gable DA, Repshas JT, Johnson TA, Andréasson U, Norgren N, Blennow K, Zetterberg H.

J Neurotrauma. 2016 Mar 16. [Epub ahead of print]

PMID:
26700106
14.

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.

Hellwig K, Kvartsberg H, Portelius E, Andreasson U, Oberstein TJ, Lewczuk P, Blennow K, Kornhuber J, Maler JM, Zetterberg H, Spitzer P.

Alzheimers Res Ther. 2015 Dec 24;7(1):74. doi: 10.1186/s13195-015-0161-y.

15.

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid.

Bittner T, Zetterberg H, Teunissen CE, Ostlund RE Jr, Militello M, Andreasson U, Hubeek I, Gibson D, Chu DC, Eichenlaub U, Heiss P, Kobold U, Leinenbach A, Madin K, Manuilova E, Rabe C, Blennow K.

Alzheimers Dement. 2016 May;12(5):517-26. doi: 10.1016/j.jalz.2015.09.009. Epub 2015 Nov 10.

16.

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements.

Bjerke M, Andreasson U, Kuhlmann J, Portelius E, Pannee J, Lewczuk P, Umek RM, Vanmechelen E, Vanderstichele H, Stoops E, Lewis J, Vandijck M, Kostanjevecki V, Jeromin A, Salamone SJ, Schmidt O, Matzen A, Madin K, Eichenlaub U, Bittner T, Shaw LM, Zegers I, Zetterberg H, Blennow K.

Clin Chem Lab Med. 2016 Jul 1;54(7):1177-91. doi: 10.1515/cclm-2015-0733.

17.

Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.

Johansson P, Almqvist EG, Wallin A, Johansson JO, Andreasson U, Blennow K, Zetterberg H, Svensson J.

Neurosci Lett. 2015 Nov 16;609:58-62. doi: 10.1016/j.neulet.2015.10.006. Epub 2015 Oct 8.

PMID:
26453765
18.

Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis.

Paterson RW, Toombs J, Slattery CF, Nicholas JM, Andreasson U, Magdalinou NK, Blennow K, Warren JD, Mummery CJ, Rossor MN, Lunn MP, Crutch SJ, Fox NC, Zetterberg H, Schott JM.

J Neurol. 2015 Dec;262(12):2722-30. doi: 10.1007/s00415-015-7904-3. Epub 2015 Sep 26.

PMID:
26410752
19.

Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.

Åberg D, Johansson P, Isgaard J, Wallin A, Johansson JO, Andreasson U, Blennow K, Zetterberg H, Åberg ND, Svensson J.

J Alzheimers Dis. 2015;48(3):637-46. doi: 10.3233/JAD-150351.

PMID:
26402100
20.

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.

Portelius E, Zetterberg H, Skillbäck T, Törnqvist U, Andreasson U, Trojanowski JQ, Weiner MW, Shaw LM, Mattsson N, Blennow K; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2015 Nov;138(Pt 11):3373-85. doi: 10.1093/brain/awv267. Epub 2015 Sep 15.

PMID:
26373605
Items per page

Supplemental Content

Loading ...
Write to the Help Desk